METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 18 mg modified release tablet bottle - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 18 mg modified release tablet bottle
AUST R: 370912
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Tablet, modified release

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 288 382

Deletion from market:
25 Nov 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products